L’esport (encara que sigui extrem) és salut? Jonatan R Ruiz, PhD ([email protected]) Investigador Ramón y Cajal Facultad de Ciencias del Deporte Universidad de Granada Manresa 12 Noviembre 2011 Daily physical activity energy expenditure in contemporary Western societies is only ~38% of that of our Palaeolithic ancestors physical activity (Cordain et al 1998) Daily physical activity energy expenditure in contemporary Western societies is only ~38% of that of our Palaeolithic ancestors physical activity (Cordain et al 1998) Physical inactivity has become one of the major public health problems of the 21st century (Blair 2009) ¿Somos ciudadanos del Paleolitico viviendo en el siglo 21? ¿Serán aquellos que tienen un estilo de vida más parecido al de nuestros antepasados los que tendrán un menor riesgo de desarrollar enfermedades crónicas y por tanto una mayor esperanza de vida? Salud Riesgo para la salud Actividad Física y Salud: Modelo teórico Actividad Física Soldier Pheidippides (530-490 BC) Marathon to Athens (~40 km) Hipócrates (~ 450 años a.c.) “...nadie pone en juego su salud tanto como los atletas” Galeno (~ 150 años a.c.) “Los atletas viven una vida contraria a los preceptos de la higiene…Cuando los atletas dejan su profesión entran en una situación peligrosa: algunos mueren enseguida, otros viven algunos años pero no llegan a viejos” 1700 Bernardino Ramazzini (1633 –1714) Padre de la medicina del trabajo estudió más de 52 ocupaciones de su época y los efectos en sus trabajadores Sastres vs mensajeros profesionales Ramazzini, B. Disease of Workers (in Latin) (translated by W.C. Wright). New York: Hafner. (1700/1964) 1873 J. E. Morgan, 1873 “El ejercicio intenso es malo para la salud”. Morgan, J. University Oars, Being a critical Enquiry into the After Health of Men Who Rowed in the Oxford and Cambridge BoatRace from the Year 1829-1869, Based on the Personal Experiences of the Rowers Themselves. London: MacMillan. (1873). Introduction of professional running in the U.S. 1909 Introduction of professional running in the U.S. New York Times, 1909 “...Sólo los superdotados pueden acabar la maratón, y aún a riesgo de dañar su corazón y de acortar su vida”. 1909 1939 The longevity of endurance athletes 1939 ( longevity) A study of those who rowed in the Oxford and Cambridge boat race from 1829-1928. BMJ 1:657:662, 1939 Hartley PHS & Llewellyn GF The Lancet Morris et al. Lancet 2: 1207-10, 1980. 1953 1953 1953 31 000 London Transport Workers Morris et al. Lancet 1953 1953 1953 Former athletes (Cases) 834, sprint and endurance runners, cricketers and rugby players Non-athletes (Controls) 761 ‘Intellectuals’ (academically distinguished) and random controls, both from Cambridge 1953 1956 JAMA Life expectancy of 629 athletes vs 583 controls All deaths included Athletes Non-athletes Excluding accidental deaths Athletes Non-athletes Mean Life Mean age at Expectancy, yr Death, yr 65.96 73.86 65.97 74.24 65.96 65.99 74.43 74.59 1956 JAMA Life expectancy of 629 athletes vs 583 controls All deaths included Athletes Non-athletes Excluding accidental deaths Athletes Non-athletes Mean Life Mean age at Expectancy, yr Death, yr 65.96 73.86 65.97 74.24 65.96 65.99 74.43 74.59 SOS! Moorstein All members of the 1948 Harvard rowing crew had died by 1968 from “various cardiac diseases” Moorstein, B. Life expectancy of Ivy League rowing crews. JAMA 205, 106 (1968). 1968 1971 Former athletes (Cases) Danish athletic champions in 19 different sports (n=297, born between 1880- 1910) Non-athletes (Controls) General Danish male population 1971 ~39% lower risk of death 1972 JAMA Harvard and Yale University oarsmen (n=172) matriculating during 1882-1902 Prout C. Life expectancy of college oarsmen. JAMA 1972 Jun 26;220(13):1709-1711 1972 Average life span of crew member and controls +6 years Prout C. Life expectancy of college oarsmen. JAMA 1972 Jun 26;220(13):1709-1711 1974 396 Finish champions skiers (born from 1845 to 1910) Median life expectancy: 73 1974 2.8 y longer life expectancy ↓Blood pressure ↓Smoke ↑Physical activity 1983 822 rugby players (blacks) from New Zealand since 1884 1983 No differences of life expectancy with normal population Non-Maory all black live 10 years than Maori all Blacks 1988 NEJM U.S. white baseball players (n=985; started playing between 1911-1915) 1988 Life expectancy ↑6% Relative Risk of Mortality Capacidad aeróbica y riesgo de mortalidad 1989 5 4 3 2 1 0 <5 Very Low Adults 6 7 Low 8 9 Medium 10 11 High 12 >13 METS Very high Cardiorespiratory Fitness Blair et al. JAMA351989 1990 Non-professional Dutch male ice skaters (n=2,259) able to finish ultra-endurance (200km) races van Saase JL, et al . BMJ 1990 Dec 22-29;301(6766):1409-1411 All cause mortality 1990 24% lower than expected during the entire 32 year follow up period. 47% lower was found during the first 10 years after the race Increased life expectancy of world class male athletes 1993 Cases Controls 2613 Finnish team members in the Olympic 1712 men selected from the games, World or European championships or Finnish Defence Forces intercountry competitions during 1920-1965 in track and field athletics, cross-country skiing, soccer, ice hockey, basketball, boxing, wrestling, weight lifting, and shooting Sarna S, Sahi T, Koskenvuo M, et al. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993 Feb;25(2):237-244 1993 Increased life expectancy of world class male athletes 77 76 75 years 74 Endurance 73 Team games 72 Power athletes 71 Controls 70 69 68 67 1 Sarna S, Sahi T, Koskenvuo M, et al. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993 Feb;25(2):237-244 1996 39 sujetos (13 mujeres) que completaron el Ironman de Hawai 1994 (3.9 km nadando; 180.2 km en bici; 42.2 km corriendo) 1996 1996 2006 Int J Sports Med 2006 Jul;27(7):587-9 2006 METODOLOGÍA Sierra Nevada Límite 2400 m 95km 2006 METODOLOGÍA justo al término 1 día antes Perfil lipídico (TC, HDL, LDL, TG) Susceptibilidad oxidativa 11 ciclistas Perfil lipídico (TC, HDL, LDL, TG) Susceptibilidad oxidativa RESULTADOS COLESTEROL TOTAL TRIGLICÉRIDOS 190 80 185 70 180 60 175 50 170 40 165 30 160 pre post 20 pre LOW DENSITY LIPOPROTEIN Chol post HIGH DENSITY LIPOPROTEIN Chol 80 120 115 70 110 60 105 100 50 95 40 90 30 85 20 80 pre post 2006 pre post 2006 Susceptibilidad a la peroxidación lipídica Susceptibility to Lipid Peroxidation (µm/L) RESULTADOS 16 14 P<0.001 12 10 8 6 4 2 0 Pre-race Post-race 2006 16 14 P<0.001 12 10 8 6 4 2 Susceptibility to Lipid Peroxidation (µm/L) 16 Susceptibility to Lipid Peroxidation (µm/L) RESULTADOS Y DISCUSIÓN Susceptibilidad a la peroxidación lipídica 14 P<0.001 12 10 8 6 4 2 0 0 Pre Post Ruiz et al., 2004 Pre Post Ginsburg et al.,1996; 2001 1. Nivel de Condición Física de los sujetos 2. Hipoxia Davies et al., Biochem Biophys Res Commun 1982; Ginsbrug et al., JAMA 1996; Ginsburg et al., Clin Chem Acta 2001 2006 CONCLUSIONES 1. El perfil lipídico plasmático no se mejora tras un ejercicio de resistencia realizado en hipoxia moderada en sujetos no entrenados 2. La susceptibilidad a la peroxidación lipídica incrementa tras un ejercicio de resistencia realizado en hipoxia moderada 2001 Cohort of athletes (n=2,009) including endurance sports, team games, track&field jumpers and sprinters, and power athletes 2001 43% 22% 10% 2001 44% 40% 5% 2001 27% 66% +2.63% 2001 0% 73% 42% 2001 86% 63% 54% 2008 Annual self-administered questionnaires were sent to 538 members of a nationwide running club and 423 healthy controls from Northern California aged 50 years and older beginning in 1984 Participants: 284 runners and 156 controls completed 21-years of follow-up (up to 2003) Runners’ Club members versus Community Control subjects 2008 Mean disability by year Disability in Ever-Runners versus Never-Runners 2008 Mortality estimates 2008 15% of runners died 34% of controls died 2008 Conclusion Vigorous exercise (running) at middle and older ages is associated with reduced disability in later life and a notable survival advantage Tour de France Tour de France 6000 Total km per race 5500 World War I World War II 5000 4500 4000 3500 3000 2500 2000 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 Years Lucia et al 2003 Maurice Garin, primer vencedor del Tour (1903) 25 kg Tour de France Primer español: Vicence Blanco 2011 834 cyclists from Tour de France (1930 and 1964) Países participantes 2011 Life expectancy Tour de France 2011 11% ↑ The age at which 50 % of the general population died was 73.5 vs. 81.5 years in TdF participants Conclusiones El ejercicio de resistencia mejora la esperaza de vida Está en nuestros genes? Study 1: Endurance athletes vs controls N=100 CASES: male elite endurance athletes (Europe/World Champions, Tour de France finishers/winners) N=100 CONTROLS: male sedentary controls OUTCOME: N=33 disease risk-related genetic variants Gomez-Gallego et al 2010 Study 1: Endurance athletes vs controls CONCLUSION: no evidence that male elite endurance athletes are genetically predisposed to have lower disease risk than matched nonathletic control subjects Gomez-Gallego et al 2010 Study 2: centenarians vs controls N=54 CASES: Centenarians 100-108 years, 48 women N=87 CONTROLS: ethnically matched healthy controls (19–43 years) 47 women) OUTCOME: N=62 disease risk-related genetic variants Ruiz et al 2011 Study 2: centenarians vs controls Disease category/subcategory Health-related (global) Cardiometabolic risk (global) Cardiovascular disease Hypertension Thrombosis/ischemic stroke Dyslipidemia Insulin resistance Cancer (global) Lung cancer Breast cancer* Other types Exceptional longevity No. of variants 62 36 13 5 6 8 3 24 4 8 14 7 Centenarians 31.0 24.9 37.8 32.6 25.9 6.2 46.6 37.8 27.1 28.0 43.0 51.8 ± ± ± ± ± ± ± ± ± ± ± ± 0.6 0.7 1.2 2.2 1.8 1.0 2.4 1.1 2.7 2.1 1.6 2.1 Controls subjects 32.0 ± 0.5 25.3 ± 0.5 38.2 ± 1.0 38.9 ± 1.7 24.2 ± 1.4 5.4 ± 0.7 43.5 ± 1.9 40.6 ± 0.8 26.4 ± 2.0 28.2 ± 2.2 47.7 ± 1.2 53.8 ± 1.6 P** 0.263 0.664 0.790 0.026 0.445 0.531 0.306 0.048 0.830 0.963 0.020 0.457 Ruiz et al 2011 Conclusiones El ejercicio de resistencia mejora la esperaza de vida La genética no es determinante L’esport (encara que sigui extrem) és salut? Jonatan R Ruiz, PhD ([email protected]) Investigador Ramón y Cajal Facultad de Ciencias del Deporte Universidad de Granada Manresa 12 Noviembre 2011 Ruiz JR, Morán M, Arenas J, Lucia A. Br J Sports Med. 2011 Mar;45(3):159-61. Moltes gràcies per la seva atenció Jonatan R Ruiz, PhD ([email protected]) Investigador Ramón y Cajal Facultad de Ciencias del Deporte Universidad de Granada